Home
>
US Stocks
>
Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc
INO

Inovio Pharmaceuticals Inc

$7.0319.2%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
7.09
Today Low/High
7.02 / 7.16
52 Week Low/High
$5.81 / $19
P/E ratio
-12.5434
Market Cap
$1.78B

Company Details

INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with HPV. INOVIO is the first and only company to have clinically demonstrated that a DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. INOVIO's lead immunotherapy candidate, VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, cleared high-risk HPV-16 and/or HPV-18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 91% of anal cancer, and 69% of vulvar cancer. Also in development are programs targeting HPV-related cancers and a rare HPV-related disease, recurrent respiratory papillomatosis (RRP); non-HPV-related cancers glioblastoma multiforme (GBM) and prostate cancer; as well as infectious disease DNA vaccine development programs in coronaviruses associated with COVID-19 diseases and MERS, Lassa fever, Ebola, and HIV. Partners and collaborators include Advaccine, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA)/Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)/Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute (IVI), Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Richter-Helm BioLogics, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. INOVIO also is a proud recipient of 2020 Women on Boards 'W' designation recognizing companies with more than 20% women on their board of directors.
Organisation
Inovio Pharmaceuticals Inc
Headquaters
San Diego, California, US
Employees
262
Industry
Health Technology
CEO
Jong Kim

Discover more

Frequently Asked Questions

What is Inovio Pharmaceuticals Inc share price today

Can Indians buy Inovio Pharmaceuticals Inc shares?

How can I buy Inovio Pharmaceuticals Inc shares from India?

Can Fractional shares of Inovio Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Inovio Pharmaceuticals Inc stocks?

We are a SEBI registered investement advisor